Pulse Biosciences, Inc. (PLSE)
PLSE Stock Price Chart
Explore Pulse Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze PLSE price movements and trends.
PLSE Company Profile
Discover essential business fundamentals and corporate details for Pulse Biosciences, Inc. (PLSE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
18 May 2016
Employees
75.00
Website
https://www.pulsebiosciences.comCEO
Paul Arthur LaViolette
Description
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
PLSE Financial Timeline
Browse a chronological timeline of Pulse Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.31, while revenue estimate is $533.33k.
Earnings released on 4 May 2026
EPS came in at -$0.27 surpassing the estimated -$0.32 by +15.62%, while revenue for the quarter reached $400.00k , beating expectations by +60.00%.
Earnings released on 19 Feb 2026
EPS came in at -$0.26 surpassing the estimated -$0.27 by +1.89%, while revenue for the quarter reached $264.00k , beating expectations by +76.00%.
Earnings released on 5 Nov 2025
EPS came in at -$0.29 surpassing the estimated -$0.31 by +6.45%, while revenue for the quarter reached $86.00k , missing expectations by -82.80%.
Earnings released on 12 Aug 2025
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%.
Earnings released on 8 May 2025
EPS came in at -$0.17 .
Earnings released on 27 Mar 2025
EPS came in at -$0.17 surpassing the estimated -$0.24 by +29.17%.
Earnings released on 30 Oct 2024
EPS came in at -$0.16 surpassing the estimated -$0.24 by +33.33%.
Earnings released on 12 Aug 2024
EPS came in at -$0.20 surpassing the estimated -$0.24 by +16.67%.
Earnings released on 7 May 2024
EPS came in at -$0.14 surpassing the estimated -$0.24 by +41.67%.
Earnings released on 28 Mar 2024
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $1.74m .
Earnings released on 13 Nov 2023
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%.
Earnings released on 10 Aug 2023
EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%.
Earnings released on 11 May 2023
EPS came in at -$0.23 falling short of the estimated -$0.22 by -4.55%.
Earnings released on 30 Mar 2023
EPS came in at -$0.22 surpassing the estimated -$0.24 by +8.33%, while revenue for the quarter reached -$9.00k , missing expectations by -104.50%.
Earnings released on 10 Nov 2022
EPS came in at -$0.46 falling short of the estimated -$0.45 by -2.22%.
Earnings released on 10 Aug 2022
EPS came in at -$0.37 matching the estimated -$0.37, while revenue for the quarter reached $265.00k , missing expectations by -39.73%.
Earnings released on 11 May 2022
EPS came in at -$0.48 surpassing the estimated -$0.51 by +5.88%, while revenue for the quarter reached $444.00k , missing expectations by -37.93%.
Earnings released on 31 Mar 2022
EPS came in at -$0.39 surpassing the estimated -$0.50 by +22.00%, while revenue for the quarter reached $844.00k , missing expectations by -3.21%.
Earnings released on 15 Nov 2021
EPS came in at -$0.42 surpassing the estimated -$0.54 by +22.22%, while revenue for the quarter reached $574.00k , missing expectations by -33.26%.
Earnings released on 9 Aug 2021
EPS came in at -$0.48 surpassing the estimated -$0.79 by +39.24%.
PLSE Stock Performance
Access detailed PLSE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
